Publications by authors named "T Loosli"

Claim this Profile
T
The effect of long-acting cabotegravir and rilpivirine treatment on drug resistance in South Africa: a modelling study.
Nuri Han, Tom Loosli, Nanina Anderegg, Anthony Hauser, Johannes Josi

Lancet Glob Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Resistance in People With Viremia on Dolutegravir-based Antiretroviral Therapy in Sub-Saharan Africa: The DTG RESIST Study.
Tom Loosli, Carolyn Bolton Moore, Lydia Buzaalirwa, Helen Byakwaga, İpek Çelikağ

Clin Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel integrase mutations linked to genotypic DTG resistance in non-B HIV-1 strains from African participants: The DTG RESIST study.
N Han, T Loosli, M Sauermann, I Çelikağ, N Anderegg

medRxiv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling study.
Andrew N Phillips, Loveleen Bansi-Matharu, Joep J van Oosterhout, Emily Hyle, David van de Vijver, Tom Loosli

Lancet HIV· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approaches to the Management of Virologic Failure on Dolutegravir-Based Antiretroviral Therapy in the 50 Countries with the Highest Adult HIV Prevalence.
Cameron T Nutt, Richard J Lessells, Winnie R Muyindike, Lyra S Johnson, Roger D Kouyos, Tom Loosli

Clin Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis